论文部分内容阅读
本文报告用人胎肝与胎胸腺、脾细胞悬液联合输注治疗慢活肝82例,与胎肝组(50例),胎胸腺、脾组(46例),常规综合治疗对照组(60例)进行对比观察,各组治疗前后比较发现ALT下降显著,P值均<0.01,以联合组降ALT幅度较大。降SB各组P<0.01,P>0.05,P>0.05,P>0.05。改善蛋白代谢各组P<0.05,P<0.05,P>0.05,P>0.05,综合评价,以三悬液联合组疗效最佳。并对三悬液联合输注的治疗机理进行了探讨。
In this paper, 82 cases of chronic active liver were treated with infusion of human embryonic liver, fetal thymus and spleen cell suspensions, and 50 cases of fetal liver, 50 cases of fetal liver, 46 cases of spleen and thymus, 60 cases of conventional combined treatment ) Were compared before and after treatment found that ALT decreased significantly before and after treatment, P values were <0.01, combined with ALT amplitude larger. SB decreased P <0.01, P> 0.05, P> 0.05, P> 0.05. Improve the protein metabolism of each group P <0.05, P <0.05, P> 0.05, P> 0.05, the comprehensive evaluation of the three suspension combination best effect. The mechanism of the three infusion combined infusion was discussed.